🇺🇸 FDA
Pipeline program

Lanthanum carbonate

SPD405-403

Approved small_molecule terminated

Quick answer

Lanthanum carbonate for Kidney Diseases is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 2 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Kidney Diseases
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials